NASDAQ: RXRX - Recursion Pharmaceuticals, Inc.

Yield per half year: -8.45%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Recursion Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. работает как биотехнологическая компания на клинической стадии, расшифровывающая биологию путем интеграции технологических инноваций в области биологии, химии, автоматизации, науки о данных и инженерии для индустриализации открытия лекарств. В нем есть четыре кандидата на клинические препараты, предназначенные для лечения редких моногенных заболеваний; и 33 дополнительных программы на разных стадиях доклинической разработки. Recursion Pharmaceuticals, Inc. имеет стратегические соглашения с Bayer; Государственный инновационный фонд Огайо; Chromaderm, Inc .

more details
; и Takeda Pharmaceutical Company Limited. Компания была основана в 2013 году и базируется в Солт-Лейк-Сити, штат Юта.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-04-16
ISIN US75629V1044
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.recursion.com
Цена ао 6.02
Change price per day: -2.51% (6.17)
Change price per week: -3.61% (6.24)
Change price per month: -21.48% (7.66)
Change price per 3 month: -13.83% (6.98)
Change price per half year: -8.45% (6.57)
Change price per year: -44.2% (10.78)
Change price per 3 year: -10.09% (6.69)
Change price per 5 year: 0% (6.015)
Change price per 10 year: 0% (6.015)
Change price per year to date: -16.92% (7.24)
All parameters

Underestimation

Title Value Grade
P/S 50.31 1
P/BV 4.84 3
P/E 0 0
EV/EBITDA -5.98 0
Total: 3.25

Efficiency

Title Value Grade
ROA, % -50.19 0
ROE, % -70.79 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0229 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 2128.75 10
Yield Ebitda, % 419.17 10
Yield EPS, % 186.97 10
Total: 10
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
14.11.2024 15.11.2024 Gibson Christopher
Chief Executive Officer		 Sale 7.35 147 000 20000 0 -0.01 link
13.11.2024 15.11.2024 Gibson Christopher
Chief Executive Officer		 Sale 7.74 154 800 20000 0 -0.01 link
27.08.2024 27.08.2024 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 12 400 5000 0 0 link
23.07.2024 25.07.2024 Borgeson Blake
Director		 Sale 8.48 97 071 11447 0 -0.01 link
27.06.2024 28.06.2024 Marriott Tina
President and COO		 Sale 7.21 43 260 6000 0 0 link
27.06.2024 28.06.2024 Marriott Tina
President and COO		 Purchase 1.06 6 360 6000 0 0 link
25.06.2024 27.06.2024 Borgeson Blake
Director		 Sale 9.51 108 861 11447 0 -0.01 link
06.06.2024 07.06.2024 Gibson Christopher
Chief Executive Officer		 Sale 9 450 000 50000 0 -0.03 link
05.06.2024 07.06.2024 Gibson Christopher
Chief Executive Officer		 Sale 8.42 421 000 50000 0 -0.03 link
17.04.2024 18.04.2024 Secora Michael
Chief Financial Officer		 Sale 7.58 175 280 23124 0 -0.01 link
17.04.2024 18.04.2024 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
16.04.2024 18.04.2024 Secora Michael
Chief Financial Officer		 Sale 7.67 191 750 25000 0 -0.02 link
16.04.2024 18.04.2024 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
16.04.2024 18.04.2024 Borgeson Blake
Director		 Sale 7.66 87 684 11447 0 -0.01 link
13.03.2024 14.03.2024 Secora Michael
Chief Financial Officer		 Sale 11.03 275 750 25000 0 -0.02 link
13.03.2024 14.03.2024 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
12.03.2024 14.03.2024 Secora Michael
Chief Financial Officer		 Sale 10.46 261 500 25000 0 -0.02 link
12.03.2024 14.03.2024 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
20.02.2024 21.02.2024 Borgeson Blake
Director		 Sale 12.32 247 065 20054 0 -0.01 link
14.02.2024 15.02.2024 Secora Michael
Chief Financial Officer		 Sale 10.46 261 500 25000 0 -0.02 link
14.02.2024 15.02.2024 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
13.02.2024 15.02.2024 Secora Michael
Chief Financial Officer		 Sale 9.86 246 500 25000 0 -0.02 link
13.02.2024 15.02.2024 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
06.02.2024 08.02.2024 Borgeson Blake
Director		 Sale 9.3 106 457 11447 0 -0.01 link
25.01.2024 29.01.2024 Larson Tina Marriott
President and COO		 Sale 10.35 82 800 8000 0 -0.01 link
25.01.2024 29.01.2024 Larson Tina Marriott
President and COO		 Purchase 1.06 8 480 8000 0 0.01 link
23.01.2024 25.01.2024 Borgeson Blake
Director		 Sale 10.58 212 171 20054 0 -0.01 link
09.01.2024 11.01.2024 Borgeson Blake
Director		 Sale 13.62 273 135 20054 0 -0.01 link
09.01.2024 11.01.2024 Li Dean Y
Director		 Sale 13.66 396 140 29000 0 -0.02 link
03.01.2024 05.01.2024 Gibson Christopher
Chief Executive Officer		 Sale 9.51 237 750 25000 0 -0.02 link
03.01.2024 05.01.2024 Gibson Christopher
Chief Executive Officer		 Sale 9.49 292 795 30853 0 -0.02 link
03.01.2024 05.01.2024 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 77 500 31250 0 0.02 link
05.09.2023 07.09.2023 Borgeson Blake
Director		 Sale 8.79 78 099 8885 0 -0.01 link
19.07.2023 19.07.2023 Secora Michael
Chief Financial Officer		 Sale 15.53 388 250 25000 0 -0.02 link
19.07.2023 19.07.2023 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
18.07.2023 19.07.2023 Virani Shafique
Chief Business Officer		 Sale 13.74 412 200 30000 0 -0.02 link
18.07.2023 19.07.2023 Virani Shafique
Chief Business Officer		 Purchase 2.22 66 600 30000 0 0.02 link
18.07.2023 19.07.2023 Secora Michael
Chief Financial Officer		 Sale 13.63 340 750 25000 0 -0.02 link
18.07.2023 19.07.2023 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
17.07.2023 19.07.2023 Virani Shafique
Chief Business Officer		 Sale 11.72 351 600 30000 0 -0.02 link
17.07.2023 19.07.2023 Virani Shafique
Chief Business Officer		 Purchase 2.22 66 600 30000 0 0.02 link
14.06.2023 15.06.2023 Secora Michael
Chief Financial Officer		 Sale 10.07 251 750 25000 0 -0.02 link
14.06.2023 15.06.2023 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
13.06.2023 15.06.2023 Secora Michael
Chief Financial Officer		 Sale 9.93 248 250 25000 0 -0.02 link
13.06.2023 15.06.2023 Secora Michael
Chief Financial Officer		 Purchase 2.22 83 250 37500 0 0.02 link
13.06.2023 15.06.2023 Borgeson Blake
Director		 Sale 9.98 154 540 15485 0 -0.01 link
06.04.2023 07.04.2023 Gibson Christopher
Chief Executive Officer		 Sale 6.64 265 600 40000 0 -0.03 link
05.04.2023 07.04.2023 Gibson Christopher
Chief Executive Officer		 Sale 6.46 86 092 13327 0 -0.01 link
21.03.2023 23.03.2023 Borgeson Blake
Director		 Sale 7.4 65 749 8885 0 -0.01 link
02.03.2023 06.03.2023 Gibson Christopher
Chief Executive Officer		 Sale 7.91 19 775 2500 0 0 link
02.03.2023 06.03.2023 Gibson Christopher
Chief Executive Officer		 Sale 7.92 146 520 18500 0 -0.01 link
24.01.2023 26.01.2023 Borgeson Blake
Director		 Sale 8.71 77 388 8885 0 -0.01 link
05.01.2023 06.01.2023 Gibson Christopher
Chief Executive Officer		 Sale 7.38 18 450 2500 0 0 link
05.01.2023 06.01.2023 Gibson Christopher
Chief Executive Officer		 Sale 7.39 136 715 18500 0 -0.01 link
01.12.2022 02.12.2022 Gibson Christopher
Chief Executive Officer		 Sale 9.27 23 175 2500 0 0 link
01.12.2022 02.12.2022 Gibson Christopher
Chief Executive Officer		 Sale 9.02 335 634 37210 0 -0.02 link
01.12.2022 02.12.2022 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 77 500 31250 0 0.02 link
14.10.2022 18.10.2022 Virani Shafique
Chief Business Officer		 Sale 10.92 109 200 10000 0 -0.01 link
14.10.2022 18.10.2022 Virani Shafique
Chief Business Officer		 Purchase 2.22 11 100 5000 0 0 link
06.10.2022 07.10.2022 Gibson Christopher
Chief Executive Officer		 Sale 11.64 29 100 2500 0 0 link
06.10.2022 07.10.2022 Gibson Christopher
Chief Executive Officer		 Sale 11.58 417 494 36053 0 -0.02 link
06.10.2022 07.10.2022 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 77 500 31250 0 0.02 link
29.09.2022 03.10.2022 Larson Tina Marriott
President and COO		 Sale 10.86 173 760 16000 0 -0.01 link
29.09.2022 03.10.2022 Larson Tina Marriott
President and COO		 Purchase 1.06 16 960 16000 0 0.01 link
01.09.2022 02.09.2022 Gibson Christopher
Chief Executive Officer		 Sale 10.5 26 250 2500 0 0 link
01.09.2022 02.09.2022 Gibson Christopher
Chief Executive Officer		 Sale 10.34 378 092 36566 0 -0.02 link
01.09.2022 02.09.2022 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 77 500 31250 0 0.02 link
04.08.2022 05.08.2022 Gibson Christopher
Chief Executive Officer		 Sale 9.45 23 625 2500 0 0 link
04.08.2022 05.08.2022 Gibson Christopher
Chief Executive Officer		 Sale 9.49 349 469 36825 0 -0.02 link
04.08.2022 05.08.2022 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 77 500 31250 0 0.02 link
08.04.2022 12.04.2022 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 109 145 44010 0 0.03 link
08.04.2022 12.04.2022 Gibson Christopher
Chief Executive Officer		 Sale 6.71 16 775 2500 0 0 link
08.04.2022 12.04.2022 Gibson Christopher
Chief Executive Officer		 Sale 6.59 243 303 36920 0 -0.02 link
07.04.2022 11.04.2022 Gibson Christopher
Chief Executive Officer		 Sale 6.51 16 275 2500 0 0 link
07.04.2022 11.04.2022 Gibson Christopher
Chief Executive Officer		 Sale 6.54 240 136 36718 0 -0.02 link
07.04.2022 11.04.2022 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 109 145 44010 0 0.03 link
06.04.2022 08.04.2022 Gibson Christopher
Chief Executive Officer		 Sale 6.56 16 400 2500 0 0 link
06.04.2022 08.04.2022 Gibson Christopher
Chief Executive Officer		 Sale 6.77 242 542 35826 0 -0.02 link
06.04.2022 08.04.2022 Gibson Christopher
Chief Executive Officer		 Purchase 2.48 109 145 44010 0 0.03 link
14.01.2022 14.01.2022 Gibson Christopher
Chief Executive Officer		 Sale 13.57 3 446 780 254000 0 -0.16 link
13.01.2022 14.01.2022 Gibson Christopher
Chief Executive Officer		 Sale 14.33 1 246 710 87000 0 -0.06 link
16.12.2021 20.12.2021 Larson Tina Marriott
President and COO		 Sale 18.74 46 850 2500 0 0 link
09.12.2021 10.12.2021 Gibson Christopher
Chief Executive Officer		 Sale 20.01 21 731 1086 0 0 link
08.12.2021 10.12.2021 Gibson Christopher
Chief Executive Officer		 Sale 20.15 214 880 10664 0 -0.01 link
08.12.2021 10.12.2021 Gibson Christopher
Chief Executive Officer		 Purchase 2.47 70 756 28646 0 0.02 link

Institutions Volume Share, %
Baillie Gifford and Company 24179504 10.65
ARK Investment Management, LLC 20654287 9.09
Vanguard Group Inc 15665210 6.9
Mubadala Investment Co PJSC 12985927 5.72
Blackrock Inc. 12393872 5.46
State Street Corporation 12151646 5.35
FMR, LLC 10897287 4.8
Kinnevik AB (publ) 10405668 4.58
Sumitomo Mitsui Trust Holdings, Inc. 9203780 4.05
Nikko Asset Management Americas, Inc. 9203780 4.05

ETF Share, % Profitability for 1 year, % Dividends, %
ARK Genomic Revolution ETF 6.45616 -8.08 0.05494
ARK Innovation ETF 2.39795 34.1 0.00666
Range Cancer Therapeutics ETF 0.87613 47.24 0.11955
WisdomTree Artificial Intelligence and Innovation Fund 0.77027 16.27 0.58091
Virtus LifeSci Biotech Clinical Trials ETF 0.57046 63.04 0.33
Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund 0.5614 1.54 0.22433
Direxion Daily S&P Biotech Bull 3x Shares 0.23168 4067.92 0.25924
Future Tech ETF 0.18148 426.34 0.8416
Principal Healthcare Innovators ETF 0.18148 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.15403 28.58 0.8565
Nuveen ESG Small-Cap ETF 0.12757 13.91 1.41019
iShares Russell 2000 Growth ETF 0.11979 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.11 23.05 0.60264
ProShares Ultra Nasdaq Biotechnology 0.10573 51.7 0.85651
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.09519 24.75 1.59225
BNY Mellon US Small Cap Core Equity ETF 0.06369 30.07 1.75333
iShares Morningstar Small-Cap Growth ETF 0.06084 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.06084 587.89 0.72598
Vanguard Russell 2000 ETF 0.06 17.16 1.48801
SPDR S&P Kensho New Economies Composite ETF 0.05086 21.57 0.88486
iShares ESG Aware MSCI USA Small-Cap ETF 0.04563 18.09 1.49366
Schwab U.S. Small-Cap ETF 0.03694 17.47 1.51433
iShares Morningstar Small-Cap ETF 0.03054 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.03054 391.25 1.60498
ProShares UltraPro Russell2000 0.03037 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.01837 3 1.46057
Humankind US Stock ETF 0.00916 18.81 1.99919
ProShares Hedge Replication ETF 0.00872 5.92 1.47892
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.00688 17.58 1.75869
Dimensional U.S. Core Equity 2 ETF 0.00677 30.76 1.47098
FlexShares Morningstar US Market Factor Tilt Index Fund 0.0047 21.94 1.69572
SPDR Portfolio MSCI Global Stock Market ETF 0.0034 17.99 2.19607
iShares Russell 3000 ETF 0.00252 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00229 24.86 1.43354
Dimensional US Core Equity Market ETF 0.00192 30.98 1.40618
Dimensional U.S. Equity ETF 0.00153 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927



Head Job title Payment Year of birth
Ms. Tina Marriott Larson COO & President 612.69k 1975 (50 years)
Dr. Blake C. Borgeson Ph.D. Co-Founder & Director 40k 1982 (43 years)
Dr. Michael Secora Ph.D. Chief Financial Officer 524.19k 1983 (42 years)
Mr. Benjamin Mabey M.S. Chief Technology Officer N/A 1983 (42 years)
Dr. Christopher C. Gibson Ph.D. Co-Founder, CEO & Director 695.18k 1983 (42 years)
Kevin Leggat Vice President of Finance & Accounting N/A
Mr. Jared Allenbach Senior Director of Investor Relations N/A
Mr. Ryan Kelly Chief Communications Officer N/A
Mr. Nathan Hatfield Chief Legal Officer & General Counsel N/A
Dr. David J. Mauro M.D., Ph.D. Chief Medical Officer 1965 (60 years)

Address: United States, Salt Lake City, UT , 41 South Rio Grande Street - open in Google maps, open in Yandex maps
Website: http://www.recursion.com